HuiYu Pharmaceuticals (688553.SH): Ximeting injection received drug registration certificate.

Huiyu Pharmaceutical (688553.SH) announced that the company recently received the "Drug Registration Certificate" for its company product Omeprazole Injection issued by the National Medical Products Administration. Omeprazole Injection is mainly used for the treatment of gastrointestinal ulcers. The registration category of Omeprazole Injection approved for the company is Class 3 chemical drugs. It was evaluated and approved based on the technical requirements consistent with the quality and efficacy of the reference preparation. Approval through generic drug quality and efficacy consistency evaluation is considered equivalent to passing a generic drug evaluation. According to national policies, drug varieties that have passed consistency evaluation will receive greater support in areas such as medical insurance payment and procurement by medical institutions. The approval of the company's Omeprazole Injection through generic drug consistency evaluation has enhanced its competitiveness and has had a positive impact on the company's development.